Literature DB >> 27313708

Low folate levels are associated with methylation-mediated transcriptional repression of miR-203 and miR-375 during cervical carcinogenesis.

Min Hao1, Weihong Zhao1, Lili Zhang1, Honghong Wang1, Xin Yang1.   

Abstract

The aim of the present study was to investigate the correlation between a lack of folic acid and the abnormal expression of microRNA (miR)-203 and miR-375 in cervical cancer. In total, 60 tissue samples of cervical intraepithelial neoplasia (CIN) or stage IA-IIA cervical cancer (study group), and 30 samples without soluble interleukin or malignancy (control group) were examined. The expression of miR-203 and miR-375 was detected using reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and the difference in expression levels was quantified using the 2-ΔΔCq method. In addition, CaSki cervical cancer cells were cultured in vitro and treated with various concentrations of folic acid. The DNA methylation states of miR-203 and miR-375 were subsequently detected by methylation-specific PCR, and the expression levels were evaluated using RT-PCR. miR-203 and miR-375 were significantly downregulated in CIN and cervical cancer tissues, compared with the control group. There was a marked difference in terms of the expression levels of miR-375 between the two groups (P<0.05). In CaSki cells, as the concentration of folic acid increased, the positive rate of DNA methylation of miR-203 and miR-375 decreased, while the expression levels of miR-203 and miR-375 demonstrated a gradual increase, which indicated that the latter two parameters were negatively correlated (P<0.05). Compared with normal cervical tissue, the expression levels of miR-203 and miR-375 were downregulated in CIN and cervical cancer. Methylation of these two miRs was apparent in CaSki cells, and was associated with a lack of folic acid. Therefore, reduced levels of folic acid, leading to increased methylation of miR-203 and miR-375, may be significant events during cervical carcinogenesis.

Entities:  

Keywords:  cervical cancer; folic acid; methylation; microRNA-203; microRNA-375

Year:  2016        PMID: 27313708      PMCID: PMC4888264          DOI: 10.3892/ol.2016.4449

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  39 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia.

Authors:  Mark H Schiffman; Philip Castle
Journal:  J Natl Cancer Inst       Date:  2003-03-19       Impact factor: 13.506

3.  Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm.

Authors:  Tak-hong Cheung; Kwun-nok Mimi Man; Mei-yung Yu; So-fan Yim; Nelson S S Siu; Keith W K Lo; Graeme Doran; Raymond R Y Wong; Vivian W Wang; David I Smith; Michael J Worley; Ross S Berkowitz; Tony K H Chung; Yick-fu Wong
Journal:  Cell Cycle       Date:  2012-08-01       Impact factor: 4.534

4.  Unique microRNA expression profiles in cervical cancer.

Authors:  Katalin Gocze; Katalin Gombos; Krisztina Juhasz; Krisztina Kovacs; Bela Kajtar; Marta Benczik; Peter Gocze; Balazs Patczai; Istvan Arany; Istvan Ember
Journal:  Anticancer Res       Date:  2013-06       Impact factor: 2.480

5.  Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer.

Authors:  Sharyn N Lewin; Thomas J Herzog; Nicanor I Barrena Medel; Israel Deutsch; William M Burke; Xuming Sun; Jason D Wright
Journal:  Obstet Gynecol       Date:  2010-11       Impact factor: 7.661

Review 6.  DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.

Authors:  Lu Qian Wang; Chor Sang Chim
Journal:  Epigenomics       Date:  2015-02-04       Impact factor: 4.778

7.  Methylation-mediated transcriptional repression of microRNAs during cervical carcinogenesis.

Authors:  Saskia M Wilting; Wina Verlaat; Annelieke Jaspers; Nour A Makazaji; Reuven Agami; Chris J L M Meijer; Peter J F Snijders; Renske D M Steenbergen
Journal:  Epigenetics       Date:  2013-01-16       Impact factor: 4.528

8.  c-myc Gene Copy Number Variation in Cervical Exfoliated Cells Detected on Fluorescence in situ Hybridization for Cervical Cancer Screening.

Authors:  Wei-Hong Zhao; Min Hao; Xiao-Tong Cheng; Xin Yang; Zhi-Lian Wang; Ke-Yan Cheng; Fang-Li Liu; Yao-Xian Bai
Journal:  Gynecol Obstet Invest       Date:  2016-01-26       Impact factor: 2.031

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  MicroRNA-375 plays a dual role in prostate carcinogenesis.

Authors:  João Ramalho-Carvalho; Filipa Quintela Vieira; Carmen Jerónimo; Pedro Costa-Pinheiro; Jorge Torres-Ferreira; Jorge Oliveira; Céline S Gonçalves; Bruno M Costa; Rui Henrique
Journal:  Clin Epigenetics       Date:  2015-04-10       Impact factor: 6.551

View more
  5 in total

Review 1.  Dietary Modulation of the Epigenome.

Authors:  Folami Y Ideraabdullah; Steven H Zeisel
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 2.  Mechanistic Target of Rapamycin Is a Novel Molecular Mechanism Linking Folate Availability and Cell Function.

Authors:  Elena Silva; Fredrick J Rosario; Theresa L Powell; Thomas Jansson
Journal:  J Nutr       Date:  2017-06-07       Impact factor: 4.798

3.  Identification and performance evaluation of housekeeping genes for microRNA expression normalization by reverse transcription-quantitative PCR using liquid-based cervical cytology samples.

Authors:  Rhafaela Lima Causin; Danielle Pessôa-Pereira; Karen Cristina Borba Souza; Adriane Feijó Evangelista; Rui Manuel Vieira Reis; José Humberto Tavares Guerreiro Fregnani; Márcia Maria Chiquitelli Marques
Journal:  Oncol Lett       Date:  2019-09-06       Impact factor: 2.967

4.  Long non-coding RNA POU6F2-AS2 promotes cell proliferation and drug resistance in colon cancer by regulating miR-377/BRD4.

Authors:  Guangru Xu; Hongxing Zhu; Jinhua Xu; Yan Wang; Yang Zhang; Minghui Zhang; Dichao Zhu
Journal:  J Cell Mol Med       Date:  2020-02-26       Impact factor: 5.310

5.  MiR-375 Is Epigenetically Downregulated by HPV-16 E6 Mediated DNMT1 Upregulation and Modulates EMT of Cervical Cancer Cells by Suppressing lncRNA MALAT1.

Authors:  Shikai Liu; Lili Song; Hairong Yao; Liang Zhang; Dongkui Xu; Fangyuan Gao; Qian Li
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.